Moderna

News

GSK's RSV shot cleared in US for all adults

GSK is back on level pegging with its rivals in the RSV vaccine category in the US, after getting FDA approval for Arexvy in the 18 to 49 age bracket.

News

Moderna agrees $950m settlement of mRNA jab litigation

Moderna's settlement of patent litigation with Arbutus and Genevant over technology used in its Spikevax COVID vaccine could reach up to $2.25bn.

Digital

Accelerating the content lifecycle: A 7-step guide for AI in...

By integrating AI agents into medical, legal, and regulatory (MLR) processes, organisations can transform content lifecycle management.

News

Moderna closes on EU approval for combined flu/COVID jab

Moderna's combined vaccine for both flu and COVID-19 has been recommended for approval in the EU, after being knocked back in the US.

News

Arrows on grey background pointing left and right

FDA relents and will review Moderna's flu shot

The FDA will start a review of Moderna's flu jab mRNA-1010, after refusing to accept the filing last week, with a new "regulatory approach."

News

FDA says comparator dose scuppered Moderna's flu jab filing

The FDA has defended its decision to issue a refusal-to-file (RTF) letter for Moderna's new mRNA-based influenza vaccine.

GSK's RSV shot cleared in US for all adults

Moderna agrees $950m settlement of mRNA jab litigation

Accelerating the content lifecycle: A 7-step guide for AI in...

Moderna closes on EU approval for combined flu/COVID jab

FDA relents and will review Moderna's flu shot

FDA says comparator dose scuppered Moderna's flu jab filing

Hernexeos and what’s next, with Vicky Brown

Using AI-driven synthetic personas to take your insights fur...

Moderna

Editor's Picks